Correlation Between Takeda Pharmaceutical and Vulcan Materials

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Vulcan Materials at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Vulcan Materials into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical and Vulcan Materials, you can compare the effects of market volatilities on Takeda Pharmaceutical and Vulcan Materials and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Vulcan Materials. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Vulcan Materials.

Diversification Opportunities for Takeda Pharmaceutical and Vulcan Materials

-0.28

Correlation Coefficient

Takeda Pharmaceutical  Vulcan Materials

Very good diversification

The 3 months correlation between Takeda and Vulcan is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and Vulcan Materials in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vulcan Materials and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with Vulcan Materials. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vulcan Materials has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Vulcan Materials go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Vulcan Materials

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to generate 33.42 times less return on investment than Vulcan Materials. But when comparing it to its historical volatility, Takeda Pharmaceutical is 1.69 times less risky than Vulcan Materials. It trades about 0.01 of its potential returns per unit of risk. Vulcan Materials is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  21,560  in Vulcan Materials on September 14, 2024 and sell it today you would earn a total of  4,840  from holding Vulcan Materials or generate 22.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Takeda Pharmaceutical  vs.  Vulcan Materials

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Vulcan Materials

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vulcan Materials are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Vulcan Materials reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Takeda Pharmaceutical and Vulcan Materials

The main advantage of trading using opposite Takeda Pharmaceutical and Vulcan Materials positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Vulcan Materials can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vulcan Materials will offset losses from the drop in Vulcan Materials' long position.

The idea behind Takeda Pharmaceutical and Vulcan Materials pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.